思林傑(688115.SH):公司嵌入式智能儀器模塊產品主要應用場景在產線測試
格隆匯10月12日丨思林傑(688115.SH)接受特定對象調研時表示,公司嵌入式智能儀器模塊產品主要應用場景在產線測試,與傳統標準儀器檢測方案相比,公司嵌入式智能儀器模塊檢測方案成本更低,且具有無固定框架的微型化、集約化特點,大幅度的節省了產線測試需要的場地空間;同時,公司產品基於FPGA平台開發,具有可靈活配置、性價比高等優點;此外,使用嵌入式智能儀器模塊方案檢測速度更快,檢測效率更高,符合工業化大規模生產的檢測要求。公司在電、光、聲等多方面混合功能測試的能力有較大的競爭優勢,並且高端測試環節的技術、新產品方面也已經有所儲備和不斷的升級拓展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.